Discrepancies between Cystatin C–Based and Creatinine-Based eGFR

Author:

Farrington Danielle K.1ORCID,Surapaneni Aditya23ORCID,Matsushita Kunihiro2ORCID,Seegmiller Jesse C.4,Coresh Josef2ORCID,Grams Morgan E.23ORCID

Affiliation:

1. Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

3. Division of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, New York

4. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota

Abstract

Background Recent guidance suggests clinicians increase use of cystatin C for the estimation of GFR. Discrepant levels of creatinine- versus cystatin C–based eGFR (eGFRcr versus eGFRcys) can occur and might signify inaccurate estimation of GFR using creatinine alone. This study sought to enhance the knowledge of the risk factors and clinical implications of having a large eGFR discrepancy. Methods Participants in the Atherosclerosis Risk in Communities Study, a prospective cohort study of US adults, were followed over 25 years. eGFR discrepancy was measured at five clinical visits and defined as eGFRcys either 30% lower or higher than eGFRcr, the current clinical standard of care. The associations between eGFR discrepancies and kidney-related laboratory parameters were assessed using linear and logistic regression and long-term adverse outcomes, including kidney failure, AKI, heart failure, and death, using Cox proportional hazards models. Results Among 13,197 individuals (mean age 57 [SD 6] years, 56% women, 25% Black race), 7% had eGFRcys 30% lower than eGFRcr at visit 2 (1990–1992), and this proportion increased over time to 23% by visit 6 (2016–2017). By contrast, the percent with eGFRcys 30% higher than eGFRcr was relatively stable (3%–1%). Independent risk factors for having eGFRcys 30% lower than eGFRcr included older age, female sex, non-Black race, higher eGFRcr, higher body mass index, weight loss, and current smoking. Those with eGFRcys 30% lower than eGFRcr had more anemia and higher uric acid, fibroblast growth factor 23, and phosphate levels as well as higher risk of subsequent mortality, kidney failure, AKI, and heart failure compared with those with similar eGFRcr and eGFRcys values. Conclusions Having eGFRcys lower than eGFRcr was associated with worse kidney-related laboratory derangements and a higher risk of adverse health outcomes. Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_09_08_CJN0000000000000217.mp3

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference38 articles.

1. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Int Suppl.,2013

2. A new equation to estimate glomerular filtration rate;Levey;Ann Intern Med.,2009

3. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review;Earley;Ann Intern Med.,2012

4. Limitations of creatinine as a filtration marker in glomerulopathic patients;Shemesh;Kidney Int.,1985

5. Measured and estimated glomerular filtration rate: current status and future directions;Levey;Nat Rev Nephrol.,2020

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3